Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation – a retrospective analysis of the Ensure data

References

• Fanchin R, de Ziegler D, Taieb J, et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090–1094.
   PubMed Web of Science ®Google Scholar
• Ubaldi F, Bourgain C, Tournaye H, et al. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67:521–526.
   PubMed Web of Science ®Google Scholar
• Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444–1449.
   PubMed Web of Science ®Google Scholar
• Bu Z, Zhao F, Wang K, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PLoS One. 2014;9:e100011.
   PubMed Web of Science ®Google Scholar
• Xu B, Li Z, Zhang H, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril. 2012; 97:1321–1327.
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Bosdou JK, et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60000 cycles. Hum Reprod Update. 2013;19:433–457.
   PubMed Web of Science ®Google Scholar
• Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122:262–263.
   PubMedGoogle Scholar
• Wentz AC. Endometrial biopsy in the evaluation of infertility. Fertil Steril. 1980;33:121–124.
   PubMed Web of Science ®Google Scholar
• Van Vaerenbergh I, Fatemi HM, Blockeel C, et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online. 2011;22:263–271.
   PubMed Web of Science ®Google Scholar
• Bourgain C, Ubaldi F, Tavaniotou A, et al. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril. 2002;78:237–244.
   PubMed Web of Science ®Google Scholar
• Labarta E, Martínez-Conejero JA, Alamá P, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011;26:1813–1825.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Embryo cryopreservation rescues cycles with premature luteinization. Fertil Steril. 2010;93:636–641.
   PubMed Web of Science ®Google Scholar
• Vanni VS, Somigliana E, Reschini M, et al. Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles. PLoS One. 2017;12:e0176482.
   PubMed Web of Science ®Google Scholar
• Filicori M, Cognigni GE, Pocognoli P, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod. 2002;17:2009–2015.
   PubMed Web of Science ®Google Scholar
• Kyrou D, Al-Azemi M, Papanikolaou EG, et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol. 2012;162:165–168.
   PubMed Web of Science ®Google Scholar
• Oktem O, Akin N, Bildik G, et al. FSH stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization. Hum Reprod. 2017;32:643–652.
   PubMed Web of Science ®Google Scholar
• Macklon NS, Stouffer RL, Giudice LC, et al. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.
   PubMed Web of Science ®Google Scholar
• Mannaerts B, Shoham Z, Schoot D, et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers. Fertil Steril. 1993;59:108–114.
   PubMed Web of Science ®Google Scholar
• Kyrou D, Kolibianakis EM, Fatemi HM, et al. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertil Steril. 2011;96:1112–1115.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Albano C, Camus M, et al. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2004;82:102–107.
   PubMed Web of Science ®Google Scholar
• Lawrenz B, Beligotti F, Engelmann N, et al. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod. 2016;31:2554–2560.
   PubMed Web of Science ®Google Scholar
• Corifollitropin alfa ESG. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod Biomed Online. 2010;21:66–76.
   PubMed Web of Science ®Google Scholar
• LaPolt PS, Nishimori K, Fares FA, et al. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology. 1992;131:2514–2520.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Mannaerts BM, Devroey P, et al. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009;15:309–312.
   PubMed Web of Science ®Google Scholar
• Devroey P, Boostanfar R, Koper NP, et al. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2009;24:3063–3072.
   PubMed Web of Science ®Google Scholar
• Yding Andersen C, Bungum L, Nyboe Andersen A, et al. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online. 2011;23:187–195.
   PubMed Web of Science ®Google Scholar
• Schneyer AL, Fujiwara T, Fox J, et al. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab. 2000;85:3319–3330.
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Griesinger G, Teal V, et al. FSH exposure between day 8 and day of hCG administration is an independent predictor of serum progesterone rise. Accepted as ESHRE abstract 2018.
   Google Scholar
• Boostanfar R, Shapiro B, Levy M, et al. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization. Fertil Steril. 2015;104:94–103.
   PubMed Web of Science ®Google Scholar
• Griesinger G, Mannaerts B, Yding Andersen C, et al. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil Steril. 2013;100:1622–1628.
   PubMed Web of Science ®Google Scholar